(S1 (S (S (NP (NN Phosphatidylinositol) (NN 3-kinase)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (JJ Toll-like) (NN receptor) (JJ 4-mediated) (NN cytokine) (NN expression)) (PP (IN in) (NP (NN mouse) (NNS macrophages)))))))) (. .)))
(S1 (S (S (NP (JJ Recent) (NN evidence)) (VP (VBZ suggests) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NN phosphatidylinositol) (-LRB- -LRB-) (NN PI) (-RRB- -RRB-) (NN 3-kinase))) (PP (IN in) (NP (JJ various) (JJ inflammatory) (NNS responses)))))) (. .)))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (NP (NP (DT the) (NNS consequences)) (PP (IN of) (NP (NP (JJ LPS-induced) (NP (NN PI) (NN 3-kinase)) (NN activation)) (PP (IN on) (NP (NP (NP (NN cytokine)) (CC and) (NP (NN chemokine))) (NN expression)))))) (CC and) (NP (NP (DT the) (JJ intracellular) (NNS mechanisms)) (PP (IN of) (NP (JJ inflammatory) (NN activation))))) (VP (VBD were) (VP (VBN examined) (PP (IN in) (NP (NN mouse) (NNS macrophages)))))) (. .)))
(S1 (S (S (NP (NN LPS) (NN stimulation)) (VP (VBD induced) (NP (NP (DT a) (JJ complex) (NN formation)) (PP (IN between) (NP (NP (NN PI) (NN 3-kinase)) (CC and) (NP (JJ myeloid) (NN differentiation) (NN factor) (CD 88) (-LRB- -LRB-) (NN MyD88) (-RRB- -RRB-)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN followed) (PP (IN by) (NP (NP (DT an) (NN induction)) (PP (IN of) (NP (NP (NN IL-1beta)) (, ,) (NP (NP (NN tumor) (NN necrosis) (NN factor-alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF-alpha)) (-RRB- -RRB-))) (CC and) (NP (NN macrophage) (JJ inflammatory) (NN protein) (-LRB- -LRB-) (NN MIP) (-RRB- -RRB-) (CD -2))))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN induction)) (PP (PP (IN of) (NP (NN IL-1beta))) (, ,) (CONJP (CC but) (RB not)) (PP (IN of) (NP (NP (NN MIP-2)) (CC or) (NP (NN TNF-alpha)))) (, ,))) (VP (VBD was) (VP (VBN blocked) (PP (IN by) (NP (NP (DT the) (NP (NN PI) (NN 3-kinase)) (NNS inhibitors)) (NP (NP (NN LY294002)) (CC and) (NP (NN wortmannin)))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NP (NP (JJ nuclear) (NN factor-kappaB)) (PRN (-LRB- -LRB-) (NP (NN NF-kappaB)) (-RRB- -RRB-))) (NN inhibitor) (NN pyrrolidinedithiocarbamate)) (PRN (-LRB- -LRB-) (NP (NN PDTC)) (-RRB- -RRB-))) (VP (VP (VBD blocked) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (NN IL-1beta)) (CC and) (NP (NN TNF-alpha)))))) (, ,) (CC but) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NN MIP-2) (NN expression)))))) (. .)))
(S1 (S (S (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (NN PI) (NN 3-kinase)))) (VP (VBD decreased) (NP (NP (DT the) (JJ LPS-induced) (JJ transcriptional) (NN activity)) (PP (IN of) (NP (NN NF-kappaB)))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (JJ nuclear) (NN DNA) (NN binding) (NN activity)) (PP (IN of) (NP (NN NF-kappaB)))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (, ,) (SBAR (IN while) (S (NP (NP (NN NF-kappaB) (JJ nuclear) (NN localization)) (CC and) (NP (NN DNA) (NN binding))) (VP (VBP are) (ADJP (JJ necessary))))) (, ,) (NP (PRP they)) (VP (VBP are) (RB not) (ADJP (JJ sufficient) (PP (IN for) (NP (NP (JJ transcriptional) (NN activation)) (PP (IN of) (NP (DT the) (NN IL-1beta) (NN gene))) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (NN PI) (NN 3-kinase)) (NN activity))))))))))))) (. .)))
(S1 (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (PRP$ our) (NNS results)) (VP (VBP demonstrate) (SBAR (SBAR (IN that) (S (NP (NP (NN activation)) (PP (IN of) (NP (JJ Toll-like) (NN receptor) (-LRB- -LRB-) (NN TLR) (-RRB- -RRB-) (CD -4)))) (VP (VBZ results) (PP (IN in) (NP (NN PI) (NN 3-kinase-MyD88) (NN complex) (NN formation)))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (NN PI) (NN 3-kinase)) (NN activity)) (ADVP (RB selectively)) (VP (VBZ leads) (PP (TO to) (NP (NP (NN cytokine) (NN induction) (JJ downstream)) (PP (IN of) (NP (NN TLR4)))))))))) (. .)))
